Skip to content

Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist

Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02024698
Enrollment
43
Registered
2013-12-31
Start date
2014-01-31
Completion date
2014-03-31
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.

Detailed description

The purpose of this cross-over study is to evaluate the clinical performance of the ProClear-1 Day in comparison with 1-Day Acuvue® Moist®. In particular, the study will focus on lens wearing comfort.

Interventions

contact lens

DEVICEetafilcon A

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

A person is eligible for inclusion in the study if he/she: * Is between 18 and 40 years of age (inclusive) * Have the use of a mobile phone to send and receive text messages throughout the day for the duration of the study. * Has had a self-reported visual exam in the last two years * Is an adapted soft CL (Contact Lens) wearer * Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so * Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive) * Has less than 0.75D (Diopters) spectacle cylinder in each eye. * Is correctable to a visual acuity of 20/25 or better in both eyes * Has clear corneas and no active ocular disease * Has read, understood and signed the information consent letter. * Is willing to comply with the wear schedule (at least 40 hrs per week) * Is willing to comply with the visit schedule

Exclusion criteria

A person will be excluded from the study if he/she: * Has never worn contact lenses before. * Currently wears rigid gas permeable contact lenses. * Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day) * Has a CL prescription outside the range of - 1.00 to -6.00D * Has a spectacle cylinder greater than -0.50D of cylinder in either eye. * Has best corrected spectacle distance vision worse then 20/25 in either eye. * Has any systemic disease affecting ocular health. * Is using any systemic or topical medications that will affect ocular health. * Has any ocular pathology or severe insufficiency of lacrimal secretion * Has persistent, clinically significant corneal or conjunctival staining * Has active neovascularization or any central corneal scars. * Is aphakic. * Is presbyopic. * Has undergone corneal refractive surgery. * Is participating in any other type of eye related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Comfort (Subjective Assessment)BaselineSubjective Assessment of comfort on insertion at baseline for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very uncomfortable, 10=cannot feel)
Hydration (Subjective Assessment)BaselineSubjective Assessment of hydration on insertion at baseline for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very dehydrated, not hydrophilic, very dry, 10=very hydrated, ultra hydrophilic)
Vision Quality (Subjective Assessment)BaselineSubjective Assessment: Visual quality on insertion at baseline for each pair using questionnaire and rated on subjective response scale (0-10; 0= clear vision, 10=perfectly sharp)
Vision Satisfaction (Subjective Assessment)1 WeekSubjective Assessment: Vision Satisfaction for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very unsatisfied, 10=very satisfied)
Dryness (Subjective Assessment)1 WeekSubjective Assessment: Dryness During Day, Dryness Prior to Removal, Overall Dryness for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very dry, 10=no dryness)
Handling (Subjective Assessment)1 WeekSubjective Assessment: Handling on Insertion and Removal, Overall Handling for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very difficult, 10=very easy)
Eye Whiteness/Redness (Subjective Assessment)1 WeekSubjective Assessment: Eye Whiteness/Redness for each pair using questionnaire and rated on subjective response scale. (0-10; 0= significant redness, 10=totally white)
Overall Sensation of Smoothness (Subjective Assessment)1 WeekSubjective Assessment: Overall sensation of smoothness at 1 week wear for each pair when asked How would you rate the overall sensation of smoothness (deposit resistance) of the first study lenses, over the last week of wear? (Likert 1-5; 1=excellent, 2=good, 3=average, 4=below average, 5=poor)
Overall Satisfaction for Lens1 WeekSubjective Assessment: Satisfaction overall at 1 Week wear for each pair when asked Overall, how satisfied was the subject with the study lenses, during the last week, with regards to: Overall? (Likert 1-4; 1=completely satisfied, 2=somewhat satisfied, 3=somewhat dissatisfied, 4=completely dissatisfied)

Countries

United States

Participant flow

Participants by arm

ArmCount
Overall Study Group
Study participants are randomized to wear omafilcon A or etafilcon A pair of study lenses then crossover to the alternate pair.
43
Total43

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (7 Days)Withdrawal by Subject01

Baseline characteristics

CharacteristicOverall Study Group
Age, Continuous28.1 years
STANDARD_DEVIATION 5.03
Region of Enrollment
United States
43 participants
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 430 / 43
serious
Total, serious adverse events
0 / 430 / 43

Outcome results

Primary

Comfort (Subjective Assessment)

Subjective Assessment: Insertion Comfort, Comfort During Day, Comfort Prior to Removal, Comfort Overall for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very uncomfortable, 10=cannot feel)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (MEAN)Dispersion
Omafilcon AComfort (Subjective Assessment)Insertion Comfort9.15 units on a scaleStandard Deviation 1.24
Omafilcon AComfort (Subjective Assessment)Comfort During Day8.12 units on a scaleStandard Deviation 2
Omafilcon AComfort (Subjective Assessment)Comfort Prior to Removal7.20 units on a scaleStandard Deviation 2.63
Omafilcon AComfort (Subjective Assessment)Comfort Overall7.84 units on a scaleStandard Deviation 1.75
Etafilcon AComfort (Subjective Assessment)Comfort Overall8.28 units on a scaleStandard Deviation 1.58
Etafilcon AComfort (Subjective Assessment)Insertion Comfort8.65 units on a scaleStandard Deviation 1.77
Etafilcon AComfort (Subjective Assessment)Comfort Prior to Removal7.70 units on a scaleStandard Deviation 1.95
Etafilcon AComfort (Subjective Assessment)Comfort During Day8.63 units on a scaleStandard Deviation 1.5
Primary

Comfort (Subjective Assessment)

Subjective Assessment of comfort on insertion at baseline for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very uncomfortable, 10=cannot feel)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Omafilcon AComfort (Subjective Assessment)9.12 units on a scaleStandard Deviation 1.17
Etafilcon AComfort (Subjective Assessment)9.16 units on a scaleStandard Deviation 1.17
Primary

Dryness (Subjective Assessment)

Subjective Assessment: Dryness During Day, Dryness Prior to Removal, Overall Dryness for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very dry, 10=no dryness)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (MEAN)Dispersion
Omafilcon ADryness (Subjective Assessment)Dryness During Day8.05 units on a scaleStandard Deviation 1.92
Omafilcon ADryness (Subjective Assessment)Dryness Prior to Removal7.24 units on a scaleStandard Deviation 2.43
Omafilcon ADryness (Subjective Assessment)Overall Dryness7.71 units on a scaleStandard Deviation 2.06
Etafilcon ADryness (Subjective Assessment)Dryness During Day8.58 units on a scaleStandard Deviation 1.48
Etafilcon ADryness (Subjective Assessment)Dryness Prior to Removal7.70 units on a scaleStandard Deviation 1.78
Etafilcon ADryness (Subjective Assessment)Overall Dryness8.14 units on a scaleStandard Deviation 1.71
Primary

Eye Whiteness/Redness (Subjective Assessment)

Subjective Assessment: Eye Whiteness/Redness for each pair using questionnaire and rated on subjective response scale. (0-10; 0= significant redness, 10=totally white)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureValue (MEAN)Dispersion
Omafilcon AEye Whiteness/Redness (Subjective Assessment)8.63 units on a scaleStandard Deviation 1.65
Etafilcon AEye Whiteness/Redness (Subjective Assessment)9.26 units on a scaleStandard Deviation 1.11
Primary

Handling (Subjective Assessment)

Subjective Assessment: Handling on Insertion and Removal, Overall Handling for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very difficult, 10=very easy)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (MEAN)Dispersion
Omafilcon AHandling (Subjective Assessment)Insertion and Removal8.85 units on a scaleStandard Deviation 1.99
Omafilcon AHandling (Subjective Assessment)Overall8.85 units on a scaleStandard Deviation 1.99
Etafilcon AHandling (Subjective Assessment)Insertion and Removal8.44 units on a scaleStandard Deviation 1.79
Etafilcon AHandling (Subjective Assessment)Overall8.51 units on a scaleStandard Deviation 1.75
Primary

Hydration (Subjective Assessment)

Subjective Assessment: Initial Hydration, Hydration During Day, Hydration Prior to Removal for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very dehydrated, not hydrophilic, very dry, 10=very hydrated, ultra hydrophilic)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (MEAN)Dispersion
Omafilcon AHydration (Subjective Assessment)Initial Hydration9.41 units on a scaleStandard Deviation 1
Omafilcon AHydration (Subjective Assessment)Hydration During Day8.02 units on a scaleStandard Deviation 1.88
Omafilcon AHydration (Subjective Assessment)Hydration Prior to Removal7.32 units on a scaleStandard Deviation 2.44
Etafilcon AHydration (Subjective Assessment)Initial Hydration8.84 units on a scaleStandard Deviation 1.41
Etafilcon AHydration (Subjective Assessment)Hydration During Day8.47 units on a scaleStandard Deviation 1.37
Etafilcon AHydration (Subjective Assessment)Hydration Prior to Removal7.53 units on a scaleStandard Deviation 1.91
Primary

Hydration (Subjective Assessment)

Subjective Assessment of hydration on insertion at baseline for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very dehydrated, not hydrophilic, very dry, 10=very hydrated, ultra hydrophilic)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Omafilcon AHydration (Subjective Assessment)9.21 units on a scaleStandard Deviation 1.02
Etafilcon AHydration (Subjective Assessment)9.35 units on a scaleStandard Deviation 1.09
Primary

Overall Satisfaction for Lens

Subjective Assessment: Satisfaction overall at 1 Week wear for each pair when asked Overall, how satisfied was the subject with the study lenses, during the last week, with regards to: Overall? (Likert 1-4; 1=completely satisfied, 2=somewhat satisfied, 3=somewhat dissatisfied, 4=completely dissatisfied)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (NUMBER)
Omafilcon AOverall Satisfaction for LensCompletely Dissatisfied1 participants
Omafilcon AOverall Satisfaction for LensCompletely Satisfied17 participants
Omafilcon AOverall Satisfaction for LensSomewhat Satisfied18 participants
Omafilcon AOverall Satisfaction for LensSomewhat Dissatisfied5 participants
Etafilcon AOverall Satisfaction for LensSomewhat Dissatisfied7 participants
Etafilcon AOverall Satisfaction for LensCompletely Dissatisfied1 participants
Etafilcon AOverall Satisfaction for LensSomewhat Satisfied14 participants
Etafilcon AOverall Satisfaction for LensCompletely Satisfied21 participants
Primary

Overall Sensation of Smoothness (Subjective Assessment)

Subjective Assessment: Overall sensation of smoothness at 1 week wear for each pair when asked How would you rate the overall sensation of smoothness (deposit resistance) of the first study lenses, over the last week of wear? (Likert 1-5; 1=excellent, 2=good, 3=average, 4=below average, 5=poor)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureGroupValue (NUMBER)
Omafilcon AOverall Sensation of Smoothness (Subjective Assessment)Good11 participants
Omafilcon AOverall Sensation of Smoothness (Subjective Assessment)Below Average3 participants
Omafilcon AOverall Sensation of Smoothness (Subjective Assessment)Average2 participants
Omafilcon AOverall Sensation of Smoothness (Subjective Assessment)Poor0 participants
Omafilcon AOverall Sensation of Smoothness (Subjective Assessment)Excellent25 participants
Etafilcon AOverall Sensation of Smoothness (Subjective Assessment)Poor0 participants
Etafilcon AOverall Sensation of Smoothness (Subjective Assessment)Excellent24 participants
Etafilcon AOverall Sensation of Smoothness (Subjective Assessment)Good7 participants
Etafilcon AOverall Sensation of Smoothness (Subjective Assessment)Average9 participants
Etafilcon AOverall Sensation of Smoothness (Subjective Assessment)Below Average3 participants
Primary

Vision Quality (Subjective Assessment)

Subjective Assessment: Visual quality on insertion at baseline for each pair using questionnaire and rated on subjective response scale (0-10; 0= clear vision, 10=perfectly sharp)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Omafilcon AVision Quality (Subjective Assessment)9.33 units on a scaleStandard Deviation 1.59
Etafilcon AVision Quality (Subjective Assessment)9.16 units on a scaleStandard Deviation 1.79
Primary

Vision Satisfaction (Subjective Assessment)

Subjective Assessment: Vision Satisfaction for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very unsatisfied, 10=very satisfied)

Time frame: 1 Week

Population: One participant received etafilcon A twice which explains the uneven number of participants analyzed in the study results for week 1.

ArmMeasureValue (MEAN)Dispersion
Omafilcon AVision Satisfaction (Subjective Assessment)9.07 units on a scaleStandard Deviation 1.46
Etafilcon AVision Satisfaction (Subjective Assessment)9.05 units on a scaleStandard Deviation 1.34

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026